Straylight levels could be linked to corneal healing

Article

Straylight values improve over time and can be linked to the progression of corneal healing, according to a paper.

Straylight values improve over time and can be linked to the progression of corneal healing, according to a paper.

The prospective study, led by Dr Yan Wang, Tianjin Eye Hospital & Eye Institute, Ophthalmology and Visual Science Key Laboratory, Tianjin Medical University, Tianjin, China, involved 128 consecutive eyes from 66 patients. Thin-flap LASIK with a femtosecond laser was performed in 61 eyes of 31 patients and think-flap LASIK with mechanical microkeratome was performed in 67 eyes of 35 patients.

All eyes were ablated using the VIXS S4 excimer laser system after flap creation. Straylight values were measured with the C-Quant straylight meter preoperatively, 1 day, 1 week, 1 month, 6 months and 1 year postoperatively.

The mean preoperative straylight values were 0.93 ± 0.11 but the postoperative values were 1.00 ± 0.11, 0.98 ± 0.10, and 0.99 ± 0.12 at 1 day, 1 week, and 1 month, respectively in the femtosecond thin-flap LASIK group. These values decreased and returned to the preoperative levels and 6 months and 1 year postoperatively.

The postoperative-preoperative increases in straylight were more reduced in the femtosecond laser group compared to the mechanical microkeratome group at 0.05 ± 0.13 vs 0.10 ± 0.13 at 1 month postoperatively. There was a significant negative correlation between preoperative straylight values and postoperative-preoperative increases.

Straylight levels return to preoperative levels and the results indicate this could be related to the progression of corneal healing.

Please visit the Journal of Refractive Surgery to read the abstract.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.